Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® C. Difficile specialty page provides c. difficile-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Disinfectants and the Rise of the Resistant Bug
As emerging infectious diseases and resistant bugs become a growing issue, the need for stronger disinfectants becomes even more vital.
Beta-Lactam Allergy Linked to Worse Clinical Outcomes
On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Gary Huang, MD, PhD, explained his research team's findings regarding self-reported allergy to drugs containing β-lactams.
Up-and-Coming Prevention Methods for <em>Clostridium difficile</em>
Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University sat down with Contagion™ to discuss up-and-coming prevention methods for C. diff in the hospital setting.
Vancomycin May Be More Effective for Treating Severe <em>C. diff</em> Infections
In a new study, researchers found that patients with severe Clostridium difficile (C. diff) infections who were treated with vancomycin had lower mortality rates than patients who were treated with metronidazole.
Reducing Antibiotics Cuts <i>C. difficile</i> rates
A new study from the United Kingdom highlights the importance of antibiotic restriction in the reduction of hospital-acquired C. difficile infections.
Pfizer's <i>C. difficile</i> Vaccine Succeeds in Phase II Study
Researchers found the experimental vaccine could potentially inhibit severe diarrhea and pseudomembranous colitis by inducing a functional antibody response that can neutralize the two main disease-causing toxins (toxin A or B) produced by C. difficile.
Heartburn Medications Dealt Another Blow by New Study
A new study has provided more evidence to show that certain heartburn medications may make individuals more susceptible to gastrointestinal infections.
A Deeper Look at the Efficacy of Off-Label <em>C. difficile</em> Treatments
A new study takes a look at the efficacy of off-label treatments for Clostridium difficile (C. difficile) infection.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.